The Nation's Investment in Cancer Research
A Plan and Budget Proposal for Fiscal Year 2008
Prepared by the Director, National Cancer Institute as mandated by The National Cancer Act (P.L. 92-218)
National Cancer Institute Director
John E. Niederhuber, M.D.
Dr. John Niederhuber was appointed the 13th Director of the National Cancer Institute in August 2006. Throughout his distinguished career, he has had ties to both NCI and the National Institutes of Health. In addition to his work as a surgeon, professor, researcher, department chair, senior associate dean, and cancer center director, Dr. Niederhuber has also been the chair of the National Cancer Advisory Board, an external NCI advisor and grant reviewer, and a laboratory investigator supported by NCI and the NIH. He joined NCI in September 2005 as deputy director for translational and clinical sciences, and became NCI's acting director in June 2006. [more...]
How We Work
Introduction
As NCI supports the full continuum of cancer research, it is crucial that we observe, analyze, understand, and integrate the emerging trends that will determine how Science Leads the NCI. Tracking Advances in 2006 is key to recognizing both the impact of research results and the emergence of new findings and opportunities. Our Strategic Objectives allow the Institute to chart a course focused on targeted, collaborative efforts to realize a future free of cancer.
An organization as multi-faceted as the National Cancer Institute requires effective management at a tactical and operational level to implement its research priorities. The following section, How We Work, describes NCI's key bioscience infrastructure that enables progress in the National Cancer Program.
NCI is organized into an Office of the Director, two intramural divisions (in-house research) and five extramural divisions (support for research throughout the United States and internationally). This structure serves as the foundation for furthering discovery, development, and delivery, through mechanisms for: investigator initiated research; clinical trials; centers, networks, and consortia; technology development; surveillance and outreach; and career training and development.
The following pages describe how NCI uses its bioscience infrastructure to coordinate and collaborate with the cancer research community, in order to expedite progress against cancer. The proposed NCI budget request reflects this vital, integrated approach.
